BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

470 related articles for article (PubMed ID: 27212582)

  • 21. The Hospitalization Burden and Post-Hospitalization Mortality Risk in Heart Failure With Preserved Ejection Fraction: Results From the I-PRESERVE Trial (Irbesartan in Heart Failure and Preserved Ejection Fraction).
    Carson PE; Anand IS; Win S; Rector T; Haass M; Lopez-Sendon J; Miller A; Teerlink JR; White M; McKelvie RS; Komajda M; Zile MR; McMurray JJ; Massie B
    JACC Heart Fail; 2015 Jun; 3(6):429-441. PubMed ID: 25982110
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outcomes in patients with heart failure with preserved, borderline, and reduced ejection fraction in the Medicare population.
    Cheng RK; Cox M; Neely ML; Heidenreich PA; Bhatt DL; Eapen ZJ; Hernandez AF; Butler J; Yancy CW; Fonarow GC
    Am Heart J; 2014 Nov; 168(5):721-30. PubMed ID: 25440801
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of one-year outcome (death and rehospitalization) in hospitalized heart failure patients with left ventricular ejection fraction >50% versus those with ejection fraction <50%.
    Ezekowitz JA; Lee DS; Tu JV; Newman AM; McAlister FA
    Am J Cardiol; 2008 Jul; 102(1):79-83. PubMed ID: 18572040
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Refining the prognostic impact of functional mitral regurgitation in chronic heart failure.
    Goliasch G; Bartko PE; Pavo N; Neuhold S; Wurm R; Mascherbauer J; Lang IM; Strunk G; Hülsmann M
    Eur Heart J; 2018 Jan; 39(1):39-46. PubMed ID: 29020337
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dynamic nature of pulmonary artery systolic pressure in decompensated heart failure with preserved ejection fraction: role of functional mitral regurgitation.
    Ennezat PV; Maréchaux S; Bouabdallaoui N; Le Jemtel TH
    J Card Fail; 2013 Nov; 19(11):746-52. PubMed ID: 24263118
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnosis, Clinical Course, and 1-Year Outcome in Patients Hospitalized for Heart Failure With Preserved Ejection Fraction (from the Polish Cohort of the European Society of Cardiology Heart Failure Long-Term Registry).
    Kapłon-Cieślicka A; Tymińska A; Peller M; Balsam P; Ozierański K; Galas M; Marchel M; Crespo-Leiro MG; Maggioni AP; Drożdż J; Filipiak KJ; Opolski G
    Am J Cardiol; 2016 Aug; 118(4):535-42. PubMed ID: 27374606
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sex Differences in Left Ventricular Cavity Dilation and Outcomes in Acute Heart Failure Patients With Left Ventricular Systolic Dysfunction.
    Kajimoto K; Minami Y; Otsubo S; Sato N;
    Can J Cardiol; 2018 Apr; 34(4):477-484. PubMed ID: 29571428
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of functional tricuspid regurgitation on heart failure and death in patients with functional mitral regurgitation and left ventricular dysfunction.
    Agricola E; Stella S; Gullace M; Ingallina G; D'Amato R; Slavich M; Oppizzi M; Ancona MB; Margonato A
    Eur J Heart Fail; 2012 Aug; 14(8):902-8. PubMed ID: 22552182
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of right heart function on outcome in patients with functional mitral regurgitation and chronic heart failure undergoing percutaneous edge-to-edge-repair.
    Osteresch R; Diehl K; Kühl M; Fiehn E; Schmucker J; Backhaus T; Fach A; Wienbergen H; Hambrecht R
    J Interv Cardiol; 2018 Dec; 31(6):916-924. PubMed ID: 30397932
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Left atrial dilatation in systolic heart failure: a marker of poor prognosis, not just a buffer between the left ventricle and pulmonary circulation.
    Rossi A; Dini FL; Agricola E; Faggiano P; Benfari G; Temporelli PL; Cucco C; Scelsi L; Vassanelli C; Ghio S
    J Echocardiogr; 2018 Dec; 16(4):155-161. PubMed ID: 29476388
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dynamic severe mitral regurgitation on hospital arrival as prognostic predictor in patients hospitalized for acute decompensated heart failure.
    Kubo S; Kawase Y; Hata R; Maruo T; Tada T; Kadota K
    Int J Cardiol; 2018 Dec; 273():177-182. PubMed ID: 30274752
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence, clinical characteristics, and outcome of atrial functional mitral regurgitation in hospitalized heart failure patients with atrial fibrillation.
    Saito C; Minami Y; Arai K; Haruki S; Yagishita Y; Jujo K; Ashihara K; Hagiwara N
    J Cardiol; 2018 Oct; 72(4):292-299. PubMed ID: 29752195
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The association of left ventricular ejection fraction with clinical outcomes after myocardial infarction: Findings from the Acute Coronary Treatment and Intervention Outcomes Network (ACTION) Registry-Get With the Guidelines (GWTG) Medicare-linked database.
    Sutton NR; Li S; Thomas L; Wang TY; de Lemos JA; Enriquez JR; Shah RU; Fonarow GC
    Am Heart J; 2016 Aug; 178():65-73. PubMed ID: 27502853
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Associations of anemia and renal dysfunction with outcomes among patients hospitalized for acute decompensated heart failure with preserved or reduced ejection fraction.
    Kajimoto K; Sato N; Keida T; Sakata Y; Takano T;
    Clin J Am Soc Nephrol; 2014 Nov; 9(11):1912-21. PubMed ID: 25183660
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Left Atrial Volumetric/Mechanical Coupling Index: A Novel Predictor of Outcome in Heart Failure With Reduced Ejection Fraction.
    Benfari G; Essayagh B; Nistri S; Maalouf J; Rossi A; Thapa P; Michelena HI; Enriquez-Sarano M
    Circ Cardiovasc Imaging; 2021 Jan; 14(1):e011608. PubMed ID: 33463368
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Left ventricular reverse remodelling predicts long-term outcomes in patients with functional mitral regurgitation undergoing MitraClip therapy: results from a multicentre registry.
    Adamo M; Godino C; Giannini C; Scotti A; Liga R; Curello S; Fiorina C; Chiari E; Chizzola G; Abbenante A; Visco E; Branca L; Fiorelli F; Agricola E; Stella S; Lombardi C; Colombo A; Petronio AS; Metra M; Ettori F
    Eur J Heart Fail; 2019 Feb; 21(2):196-204. PubMed ID: 30549159
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum aldosterone is associated with mortality and re-hospitalization in patients with reduced ejection fraction hospitalized for acute heart failure: analysis from the EVEREST trial.
    Girerd N; Pang PS; Swedberg K; Fought A; Kwasny MJ; Subacius H; Konstam MA; Maggioni A; Gheorghiade M; Zannad F;
    Eur J Heart Fail; 2013 Nov; 15(11):1228-35. PubMed ID: 23787720
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outcomes in mitral regurgitation due to flail leaflets a multicenter European study.
    Grigioni F; Tribouilloy C; Avierinos JF; Barbieri A; Ferlito M; Trojette F; Tafanelli L; Branzi A; Szymanski C; Habib G; Modena MG; Enriquez-Sarano M;
    JACC Cardiovasc Imaging; 2008 Mar; 1(2):133-41. PubMed ID: 19356418
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Management of concomitant mild to moderate functional mitral regurgitation during aortic valve surgery for severe aortic insufficiency.
    Lim JY; Jung SH; Kim JB; Chung CH; Lee JW; Song H; Choo SJ
    J Thorac Cardiovasc Surg; 2014 Aug; 148(2):441-6. PubMed ID: 24199761
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence and the long-term prognosis of functional mitral regurgitation in Japanese patients with symptomatic heart failure.
    Kaneko H; Suzuki S; Uejima T; Kano H; Matsuno S; Otsuka T; Takai H; Oikawa Y; Yajima J; Koike A; Nagashima K; Kirigaya H; Sagara K; Tanabe H; Sawada H; Aizawa T; Yamashita T
    Heart Vessels; 2014 Nov; 29(6):801-7. PubMed ID: 24275908
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.